RXDX-103

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRXDX-103
Drug Alias NameNMS-P862RXDX-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division cycle 7-related protein kinase inhibitors
TargetsCell division cycle 7-related protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNerviano Medical Sciences Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche LtdNerviano Medical Sciences Srl
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A